Collective expert perspectives on the use of safinamide as adjunctive therapy for parkinson’s disease: online-based delphi survey

HIGHLIGHTS

  • who: Delphi Survey et al. from the Department of Neurology, National Hospital Organization, Sendai Nishitaga Hospital, Kagitorihoncho, Sendai Taihaku-ku, Miyagi, Japan Department of Cognitive and Motor Aging, Tohoku University Graduate School of Medicine, Seiryo-machi, Sendai Aoba-ku have published the research: Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinsonu2019s Disease: Online-Based Delphi Survey, in the Journal: Parkinson`s Disease of 15/07/2022
  • what: The results of this study provide useful information as a clinical practice guide for safinamide in patients with wearing-off.
  • future . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?